HOME >> BIOLOGY >> NEWS
Virginia Tech Researchers Receive Patent For Rapid Virus Detection Technology

BLACKSBURG, Va., June 19, 1996 -- Outbreaks of intestinal diseases due to contaminated water are on the rise worldwide, and over half of these outbreaks are caused by viruses, according to Charles Hagedorn, Virginia Tech professor of crop and soil environmental sciences.

Marian Ijzerman, a 1994 Ph.D. graduate now with the EPA, along with Hagedorn, her advisor, and biology professor Joe Falkinham, have received a patent (Number 5,527,667 on June 18, 1996) for a "Rapid Virus Detection Technology," which they developed for drinking water, recreational waters, and groundwater.

The test can be used at water treatment plants and in process water used by food and pharmaceutical industries to let engineers know whether they have to conduct further tests for harmful viruses, Falkinham says.

The test detects the presence or absence of a virus indicator (coliphages). "The rapid virus detection technology is based on the fact that many viruses cause susceptible cells to break open and release their cellular contents as a consequence of viral infection. Thus, the release of compounds that are normally only found within cells is indicative of the possible presence of a virus," says Hagedorn.

The test detects a specific compound (an enzyme) released from cells in the test medium -- "a cellular equivalent of canaries used to detect gas in mines," says Hagedorn.

Presently, the presence of the bacterium, Escherichia coli (E. coli), is used throughout the world as an indicator of human fecal contamination of water. If viruses able to infect E. coli are present in a water sample, then its host, E. coli must also be present.

"An advantage of the rapid virus test is that viruses are usually live longer in water samples than bacterial cells, thus presence of virus can indicate previous fecal contamination of wat
'"/>

Contact: Joseph Falkinham or Charles Hagedorn
chagedor@vt.edu
540-231-5931
Virginia Tech
12-Aug-1996


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
6. Virginia Center for Coal and Energy Research helps implement global climate change initiative
7. Cell cycle research earns biologist Virginias top scientist award
8. Virginia Tech-led group receives third five-year international biodiversity grant
9. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
10. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
11. Virginia Bioinformatics Institute central to Regional Center of Excellence

Post Your Comments:
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
(Date:5/20/2015)... DUBLIN , May 19, 2015 Research and ... addition of the "Global Cell Therapy Market Outlook ... Utilization of cell therapy in tissue and regenerative medicine ... are no other options which could help in the ... in this segment but they are unable to form ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Top Technologies in the Health and Wellness Industry 2015 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
Cached News: